Canadian veterinarians are publicly urging regulatory changes as shortages of veterinary medicines continue to mount, according to a report from Global News.

The practitioners interviewed described the situation as "frustrating," a word that captures the daily reality at clinics that cannot reliably obtain the drugs they need to treat patients. The report frames the shortages not as an isolated supply hiccup but as a persistent, growing problem that now requires policy action rather than case-by-case workarounds.

What the reporting makes clear is that the pressure is coming from the practice level upward. Veterinarians on the front lines are the ones sounding the alarm, and their demand is directed at regulators: the rules governing how veterinary medicines enter and move through the market need to change so that supply can keep pace with clinical demand.

For practicing veterinarians, drug shortages translate directly into exam-room decisions. When a needed medicine is unavailable, clinicians must find alternatives, adjust protocols, or delay treatment — choices that cost time, complicate client communication, and can affect outcomes. The Global News report underscores that practitioners see the current regulatory framework as part of the problem and want reform that makes supply more resilient before shortages force those difficult substitutions.

The story is primarily a companion-animal and clinical-practice story, but medicine shortages rarely stay confined to one sector. Any prolonged disruption in veterinary pharmaceutical supply raises broader questions about continuity of care across companion-animal practice and, potentially, food-animal medicine, where treatment options are already constrained by the limited number of products approved for livestock species.

Global News does not report specific drug names, shortage counts, or a regulatory timeline, so the scope of the proposed changes and the agencies involved remain to be detailed as the story develops. What is on record is the profession's stance: the shortages are mounting, the workaround burden is unsustainable, and practitioners expect regulators to act.

How governments and veterinary regulators respond to that call is likely to shape drug availability for clinics in the months ahead.